Linguistic Strategies for Improving Informed Consent in Clinical Trials Among Low Health Literacy Patients-Reference-Cited by-同舟云学术

Linguistic Strategies for Improving Informed Consent in Clinical Trials Among Low Health Literacy Patients

Published:2016-10-28 Issue:3 Volume:109 Page:djw233
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI J Natl Cancer Inst

Author:

Krieger Janice L.,Neil Jordan M.,Strekalova Yulia A.,Sarge Melanie A.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference43 articles.

1. Participation in Cancer Clinical Trials

2. Clinical Trial Participation among Ethnic/Racial Minority and Majority Patients with Advanced Cancer: What Factors Most Influence Enrollment?

3. Institute of Medicine Forum on drug discovery, development, and translation. Transforming clinical research in the United States: Challenges and opportunities: Workshop summary. Washington, DC: National Academies Press; 2010. http://www.ncbi.nlm.nih.gov/books/NBK50892/. Accessed August 31, 2016.

4. Obstacles to participation in randomised cancer clinical trials: A systematic review of the literature

5. Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of Informed Consent in Phase III Clinical Trials in Portugal: The Participants’ Perspective;Acta Médica Portuguesa;2024-07-19

2. Informed proxy consent for ancient DNA research;Communications Biology;2024-07-04

3. Securing direct stakeholder feedback to inform clinical research in serious mental illness: Results of a patient and family perspectives survey;Psychiatry Research;2023-12

4. Beyond translations, perspectives for researchers to consider to enhance comprehension during consent processes for health research in sub-saharan Africa: a scoping review;BMC Medical Ethics;2023-06-21

5. Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit;Trials;2023-06-13